Ergoline compounds and uses thereof

作者: Miguel Guzman , Scott Borland , Ármin Szabolcs , Geoff McKinley , János Gerencser

DOI:

关键词:

摘要: Provided herein are ergoline compounds and pharmaceutical compositions thereof. In some embodiments, provided methods of treatment, prevention, or amelioration a variety medical disorders such as, for example, migraine using the disclosed herein. still other agonizing receptors 5-HT1A, 5-HT1B 5-HT1D without 5-HT2B receptor antagonizing adrenergic alpha2A and/or alpha2B D2 D3

参考文章(170)
S Bajusz, L Lowinger, I Moraycsik, S Elek, T Balogh, E Mago, J Borsi, I Polgari, Lysergic acid amides ,(1971)
Shashidhar Kori, Libo Wu, Thomas Armer, Novel ergoline derivatives and uses thereof ,(2013)
Jaswant S. Gidda, David L. Nelson, Marlene Cohen, James E. Audia, Method for treating 5-HT2B receptor related conditions ,(1995)
Richard W. Reynolds, Stephen S. Baits, Differential transmission mechanism for a constant speed drive ,(1985)
Daniel Lesieur, Frederique Klupsch, Michel Langlois, Pierre Renaud, Gerald Guillaumet, Marie-Claude Viaud, Caroline Bennejean, Philippe Delagrange, Substituted cyclic compounds ,(2004)